Skip to main content
SpringerLink
Log in

Sulfonylharnstoff-Therapie

  • Chapter
Diabetes mellitus • B

Part of the book series: Handbuch der inneren Medizin ((INNEREN 7,volume 7 / 2 / B))

  • 30 Accesses

Zusammenfassung

Nur wenige der vielen Arzneimittel, mit denen man vor 1922 versuchte, den Diabetes mellitus zu behandeln, besaßen signifikante hypoglykämische Eigenschaften, und die meisten hatten unerwünschte toxische Wirkungen. Die Entdeckung des Insulins und seiner klinischen Wirksamkeit schien jedoch das Problem des Diabetes zu lösen, und man bemühte sich danach viele Jahre lang nur wenig, nach einer Alternative für eine orale Therapie zu suchen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Achelis, J.D, Hardebeck, K: Über eine neue blutzuckersenkende Substanz. Dtsch. med. Wschr. 80, 1452–1455 (1955).

    PubMed  CAS  Google Scholar 

  • Acta Diabetologica Review: Misunderstanding or Error? The UGDP report after four years. Eds. S. Marigo etal. Acta Diabetologica Lat. 10, 357–422 (1974).

    Google Scholar 

  • Ambrogi, V, Bloch, K, Daturi, S, Griggi, P, Logemann, W, Parenti, M.A, Rabini, T, Tommasini, R: Pharmacological study on a new antidiabetic: N-(4[B-(5-methylpyrazine-2-carbox- amido)-ethyl]-benzene-sylphonyl)-N’-cyclohexylurea or K4024. Arzneimittel-Forsch. 21, 208–215 (1971).

    CAS  Google Scholar 

  • Arduino, F, Ferraz, F.P.J, Rodrigues, J: Antidiuretic action of chlorpropamide in idiopathic diabetes insipidus. J. clin. Endocr. 26, 1325–1328 (1966).

    PubMed  CAS  Google Scholar 

  • Artini, D, Abbiati, R, Otdini, G, Barenti, M.A, Bloch, K, Daturi, S, Mandelli, V: Pharmacodyamic aspects of two sulphonylurea derivatives glipiside and glibenclamide. Diabetologie, Suppl. 9, 311–316 (1973).

    CAS  Google Scholar 

  • Aumüller, V, Bänder, A, Heerdt, A, Muth, K, Pfaff, W, Schmidt, F.H, Weber, H, Weyer, R: A powerful new oral antidiabetic agent. Arzneimittel-Forsch. 16, 1640–1641 (1966).

    Google Scholar 

  • Azzopardi, J, Campbell, I.W, Clarke, B.F, Duncan, L.J.P: Duration of hypoglycaemic action of Glipizide. Med. Klin. 70, 1214–1218 (1975).

    PubMed  CAS  Google Scholar 

  • Baird, I.M, Rickards, D.F: Hypoglycaemic coma during change from insulin to tolbutamide. Brit. med. J. 1962 II, 1585.

    Google Scholar 

  • Balani, L, Zhand, G, Gorgla, A, Schwarz, R, Fabre, J: Pharmacokinetics of glipizide in man: influence of renal insufficiency. Diabetologia, Suppl. 9, 331–338 (1973).

    Google Scholar 

  • Bauer, H.G: Severe and prolonged hypoglycaemic shock during sulphonylurea treatment. Metabolism 14, 220–228 (1965).

    PubMed  CAS  Google Scholar 

  • Beaser, S.B: Therapy of diabetes mellitus with combination of drugs given orally. New Engl. J. Med. 259, 1207–1210 (1958).

    PubMed  CAS  Google Scholar 

  • Bergman, H: Hypoglycaemic coma during sulfonylurea therapy. Acta med. scand. 177, 287–298 (1965).

    PubMed  CAS  Google Scholar 

  • Berndt, W.O, Miller, M, Keltyle, W.M, Valtin, H: Potentiation of the antidiuretic effect of vasopressin by chlorpropamide. Endocrinology 86, 1028–1032 (1970).

    PubMed  CAS  Google Scholar 

  • Bernhard, H: Long-term observations on oral hypoglycemic agents in diabetes. The effect of carbutamide and tolbutamide. Diabetes 14, 59–70 (1965).

    PubMed  CAS  Google Scholar 

  • Bertram, F, Bendtfeldt, E, Otto, H: Über ein wirksames perorales Antidiabetikum (BZ 55). Dtsch. med. Wschr. 80, 1455–1460 (1955).

    PubMed  CAS  Google Scholar 

  • Bigler, F, Muitt, P, Vecchi, M, Vetter, W: Über den Stoffwechsel von Glibornurid beim „Menschen“. Arzneimittel-Forsch. 22, 2191–2198 (1972).

    CAS  Google Scholar 

  • Biometrie Society Report: Report of the Committee for the assessment of biometric aspects of controlled trials of hypoglycaemic agents. J. Amer. med. Ass. 231, 583–608 (1975).

    Google Scholar 

  • Bluch, L, Kisselbach, N.H.K, Lehnert, J: Multizentrische klinische Prüfung des neuen oralen Antidiabetikums glisoxepid (384231) IL Prüfung der Wirksamkeit in der Behandlung des Erwachsenen-Diabetes. Arzneimittel-Forsch. 24, 437–446 (1974).

    Google Scholar 

  • Bode, H.H, Harley, B.M, Crawford, J.D: Resteration of normal drinking behaviour by chlorpropamide in patients with hypodypsia and diabetes insipidus. Amer. J. Med. 51, 304–313 (1971).

    PubMed  CAS  Google Scholar 

  • Bradley, R.P, Dolger, M, Forsham, P.H, Selter, H: “Settling the UGDP Controversy.” J. Amer. med. Ass. 232, 813–817 (1975).

    CAS  Google Scholar 

  • Brandt, L, Norden, A, Swahn, B: Assessment of treatment with tolbutamide in diabetes mellitus. Acta med. scand. 169, 193–200 (1961).

    Google Scholar 

  • Breidahl, H.D, Ennis, G.C, Martin, F.I.R, Stawell, J.R, Taft, P: Insulin and oral agents II: Clinical and therapeutic aspects. Drugs 3, 204–226 (1972).

    PubMed  CAS  Google Scholar 

  • Brook, R, Schrogie, J.L, Solomon, H.M: Failure of probenecid to inhibit the rate of metabolism of tolbutamide in man. Clin. Pharm. Ther. 9, 314–317 (1968).

    CAS  Google Scholar 

  • Brotherton, P.M, Grieveson, P., McMartin, C.: A study of the metabolic fate of chlorpropamide in man. Clin. Pharmacol. Ther. 10, 505–514 (1969).

    PubMed  CAS  Google Scholar 

  • Buckert, A, Schweda, E: Therapeutic trials with RO 6-4563 in patients with maturity-onset diabetes. In: Recent Hypoglycaemic Sulfonylureas. Eds. U.C. Dubach and A. Buckert, p. 283. Stuttgart 1971.

    Google Scholar 

  • Burke, G., Silverstein, G.E., Sorkin, A.: Effect of long-term sulfonylurea therapy on thyroid function in man. Metabolism 16, 651–657 (1967).

    CAS  Google Scholar 

  • Burns, J.J.: Implications of enzyme induction for drug therapy. Amer. J. Med. 37, 327–331 (1964).

    PubMed  CAS  Google Scholar 

  • Camerini-Dävalos, R.A, Lozana-Castaneda, O., Marble, A.: Five years’ experience with tolbutamide. Diabetes 11, Suppl. 74–80 (1962).

    PubMed  Google Scholar 

  • Camerini-Dävalos, R.A., Marble, A: Incidence and cause of secondary failure in treatment with tolbutamide. Experience with 2500 patients treated up to five years. J. Amer. med. Ass. 181, 1–4 (1962).

    Google Scholar 

  • Carlstrom, S, Persson, G., Schersten, B.: Antidiabetic treatment in the prevention of cardiovascular disease of subjects with borderline glucose tolerance. Preliminary results of a prospective study. Acta Endocrinol. 77 (Suppl. 190) 7–8 (1974).

    Google Scholar 

  • Christ, O.E., Heptner, W., Rupp, W.: Investigation on absorption, excretion and metabolism in man after administration of 14C-labelled HB 419. J. Horm. Metab. Res. 1 (Suppl.), 51–54 (1969).

    Google Scholar 

  • Clarke, B.F., Campbell, I.W.: Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed maturity-onset diabetics. Lancet 19751, 246–248.

    Google Scholar 

  • Clarke, B.F., Campbell, I.W., Ewing, D.J., Beveridge, G.W., MacDonald, M.K.: Generalized hypersensitivity reaction and visceral arteritis with fatal outcome during glibenclamide therapy. Diabetes 23, 739–742 (1974).

    PubMed  CAS  Google Scholar 

  • Clarke, B.F., Duncan, L.J.P.: Combined metformin-chlorpropamide therapy in 108 diabetic sulphonylurea failures. Lancet 1965 I, 1248–1251.

    Google Scholar 

  • Clarke, B.F., Duncan, L.J.P.: Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics. Lancet 1968 I, 123–126.

    Google Scholar 

  • Clarke, B.F., Marshall, A., McGill, R.C., MacCuish, A.C., Duncan, L.J.P.: A 3-year evaluation of combined sulphonylurea-metformin treatment in 200 diabetic keto-acidosis resistant sulphonylurea failures. In: Tolbutamide — after ten years (Butterfield, Westering, eds.), pp. 312–320. New York: Excerpta Medica 1967.

    Google Scholar 

  • Cornfield, J.: The University Group Diabetes Program. A further statistical analysis of the mortality findings. J. Amer. med. Ass. 217, 1676–1687 (1971).

    CAS  Google Scholar 

  • Crockett, S.S., Marsh, D., Lewis, R.P., Tzagournis, M.: Lack of cardiac inotropic effect of tolbutamide in intact man. Metabolism 23, 763–769 (1974).

    PubMed  CAS  Google Scholar 

  • Cushman, P., Dubois, J.J., Dwyer, E., Izzo, J.L.: Protracted tolbutamide hypoglycaemia. Amer. J. Med. 35, 196–204 (1963).

    PubMed  Google Scholar 

  • Davidson, M., Lewis, A.A.C., De Mowbray, R.R., Boucher, B.J., Oakley, N.W., Nabarro, J.D.N., Gimsburg, J., Beaconsfield, P.: Metabolic and clinical effects of glibenclamide. Lancet 1970 I, 57–61.

    CAS  Google Scholar 

  • Dolger, H.B., Bookman, J.J., Nechemias, C: Tolbutamide in pregnancy and diabetes. J. Mt Sinai Hosp. 36, 471–474 (1969).

    CAS  Google Scholar 

  • Dubach, U.C., Bückert, A., Forgo, I.: Clinical pharmacological studies with a new sulphonylurea derivative RO 6-4563. In: Proceedings Seventh Congress of the Int. Diabetic Fed. Eds. R.R. Rodriguez etal., p. 89. Amsterdam: Excerpta Med. 1970.

    Google Scholar 

  • Duncan, L.J.P., Clarke, B.F.: Pharmacology and mode of action of the hypoglycaemic sulphonylureas and diguanides. Ann. Rev. Pharmacol. 5, 151–162 (1965).

    Google Scholar 

  • Duncan, L.J.P., Clarke, B.F.: Unpublished data (1971).

    Google Scholar 

  • Duncan, L.J.P., Nabarro, J.D.N., Oakley, W.G., Wolff, F.W.: A warning note. Brit. med. J. 1956 II, 454.

    Google Scholar 

  • Ehrhardt, G.: Über neue peroral wirksame blutzuckersenkende Substanzen. Naturwissenschaften 43, 93 (1956).

    Google Scholar 

  • Emanueli, A., Molari, E., Colombo, P.L., Caputo, G.: Glipizide, a new sulphonylurea in the treatment of diabetes mellitus. Arzneimittel-Forsch. 22, 1881–1885 (1972).

    CAS  Google Scholar 

  • Ewald, W, Hartmann, H.M., Haupt, E. et al.: Klinische Erfahrungen bei der Langzeitbehandlung des Erwachsenendiabetes mit Glibornurid (RO 6-4563). Med. Klin. 68, 376–385 (1973).

    PubMed  CAS  Google Scholar 

  • Fajans, S.S., Conn, J.W.: The use of tolbutamide in the treatment of young people with mild diabetes mellitus. Diabetes 11, Supp. 123–126 (1962).

    Google Scholar 

  • Fajans, S.S., Conn, J.W.: Prediabetes, subclinical and latent clinical diabetes; interpretation, diagnosis and treatment. In: On the nature and treatment of diabetes (Leibel, Wrenshall, eds.), pp. 641–655. Amsterdam: Excerpta Medica 1965.

    Google Scholar 

  • Falconer, D.S., Duncan, L.J.P., Smith, C.: A statistical and genetical study of diabetes. I. Prevalence and morbidity. Ann. hum. Genet. 34, 347 - 369 (1971).

    PubMed  CAS  Google Scholar 

  • Feinstein, A.R.: Clinical biostatics. VIII. An analytical appraisal of the University Group Diabetes Program (UGDP) Study. Clin. Pharmacol. 12, 167–191 (1971).

    CAS  Google Scholar 

  • Feldman, R., Crawford, D., Elashoff, R., Glass, A.: Oral hypoglycaemic drug prophylaxis in asymptomatic diabetes. In: Proc. Eighth Congress of the Int. Diabetic Fed. Eds. W.J. Malaisse and J. Pirart, p. 574–587. Amsterdam: Excerpta Med. 1974.

    Google Scholar 

  • Fine, D., Shedrovilzky, H.: Hyponatraemia due to chlorpropamide: a syndrome resembling inappropriate secretion of antidiuretic hormone. Ann. intern. Med. 72, 83–87 (1970).

    PubMed  CAS  Google Scholar 

  • Franke, H., Fuchs, J.: Ein neues antidiabetisches Prinzip. Ergebnisse Klinischer Untersuchungen. Dtsch. med. Wschr. 80, 1449–1452 (1955).

    PubMed  CAS  Google Scholar 

  • Fussgänger, R.D., Goberna, R., Hintz, M., Jaros, P., Karsten, C., Pfeiffer, E.F., Raptis, S.: Comparative studies on the dynamics of insulin secretion following HB 419 and tolbutamide of the perfused isolated rat pancreas and the perfused isolated pieces and islets of rat pancreas. J. Horm. Metab. Res. 1 (Suppl.), 34–40 (1969).

    Google Scholar 

  • Garcia, M., Miller, M., Moses, A.M.: Chlorpropamide-induced water retention in patients with diabetes mellitus. Ann. intern. Med. 75, 549–554 (1971).

    Google Scholar 

  • Gardner, P., Goodner, C.J., Dowling, J.T.: Severe hypoglycaemia in elderly patients receiving therapeutic doses of tolbutamide. J. Amer. med. Ass. 186, 991–993 (1963).

    CAS  Google Scholar 

  • Goldner, M. (Ed.): Symposium: Chlorpropamide and diabetes mellitus. Ann. N.Y. Acad. Sei. 74, 621–1028 (1959).

    Google Scholar 

  • Gutsche, H., Boenicke, G.: 2-Benzolsulfonamido-5 (ß-methoxy-äthoxy)-pyrimidin (Glycodiazin), ein neues orales Antidiabeticum. Arzneimittel-Forsch. 14, 409–411 (1964).

    CAS  Google Scholar 

  • Hadden, D.R., Montgomery, D.A., Weaver, J.A.: Long-term experience with chlorpropamide in diabetes mellitus. Diabetes 11, 91–95 (1962).

    Google Scholar 

  • Haupt, E., Köberich, W., Beyer, J., Schoffling, K.: Pharmacodynamic aspects of Tolbutamide, Glibenclamide, Glibornuride and Glisoxepide. I. Dose response relations and repeated administration in diabetic subjects. Diabetologia 7, 449–454 (1971 a).

    PubMed  CAS  Google Scholar 

  • Haupt, E., Köberich, W., Beyer, J., Schöffling, K.: Pharmacodynamic aspects of Tolbutamide, Glibenclamide, Glibornuride und Glisoxepide. II. Repeated administration in combination with glucose. Diabetologia 7, 455–460 (1971b).

    PubMed  CAS  Google Scholar 

  • Haupt, E., Beyer, J., Schöffling, K.: Pharmakologische Untersuchungen mit Glisoxepid und anderen blutzuckersenkenden Sulfonamidderivaten an Stoffwechselgesunden und Diabetikern. Arzneimittel-Forsch. 24, 418–425 (1974a).

    CAS  Google Scholar 

  • Haupt, E., Beyer, J., Schöffling, K.: Der Einfluß verschiedener Antidiabetika auf den oralen Glucosetoleranztest bei Stoffwechselgesunden, adipösen und erwachsenen Diabetikern. Dtsch. med. Wschr. 99, 385–388 (1974b).

    PubMed  CAS  Google Scholar 

  • Hayes, J.S., Kaye, M.: Inappropriate secretion of antidiuretic hormone induced by chlorpropamide. Amer. J. med. Sei. 263, 137–141 (1972).

    CAS  Google Scholar 

  • Hebold, G., Scholz, J., Schutz, E., Geerwek, H., Sakaguchi, T., Brunk, R., Nothdurft, H., Kief, H., Baeder, C., Hartig, F.: Experimental investigations of the new sulfonylurea derivative Glibenclamide (HB 419). J. Horm. Metab. Res. 1 (Suppl.), 4–10 (1969).

    Google Scholar 

  • Heinsen, H.A., Hagen, H.: Kritisches zur peroralen Diabetestherapie. Med. Klin. 51, 1217–1221 (1956).

    CAS  Google Scholar 

  • Henningsen, P., Benveniste, D.: Effect of tolbutamide on renal glucose reabsorption. Diabetes 15, 90–92 (1966).

    PubMed  CAS  Google Scholar 

  • Hershman, J.M., Konerding, K.: Effect of sulfonylurea drugs on the thyroid and serum protein binding of thyroxine in the rat. Endocrinology 83, 74–78 (1968).

    PubMed  CAS  Google Scholar 

  • Hildner, F.J., Ramswamy, K., Javier, R.P., Lasseter, K.C., Samet, P., Yeh, B.: Haemodynamic effects of tolbutamide in man. Circulation 44 (Suppl. 2), 178 (1971).

    Google Scholar 

  • Hunton, R.B., Wells, M.V., Skipper, E.W.: Hypothyroidism in diabetics treated with sulphonylureas. Lancet 1965 II, 449–451.

    Google Scholar 

  • Irvine, W.J., Clarke, B.F., Scarth, L., Cullen, D.R., Duncan, L.J.P.: Thyroid and gastric autoimmunity in patients with diabetes mellitus. Lancet 1970 II, 163–168.

    Google Scholar 

  • Jackson, W.P.U., Campbell, G.D., Notelovitz, M., Blumsohn, D.: Tolbutamide and chlorpropamide during pregnancy in human diabetics. Diabetes 11, Suppl. 98–101 (1962).

    PubMed  Google Scholar 

  • Janbon, M., Chapal, J., Vedel, A., Schaap, J.: Accidents hypoglycemiques graves par un sulfamido thiodiazole (le VK 57 ou 2254 RP). Montpellier med. 441, 21–22 (1942).

    Google Scholar 

  • Johannessen, A., Fagerberg, S.E.: Glipizide — a new oral antidiabetic agent. Diabetologia, Suppl. 9, 339–347 (1973).

    Google Scholar 

  • Karam, J.H., Martin, S.B., Forsham, P.H.: Antidiabetic drugs after the University Group Diabetes Program (UGDP). Ann. Rev. Pharmacol. 15, 351–366 (1975).

    PubMed  CAS  Google Scholar 

  • Katz, H.M., Bissel, G.: Blood sugar lowering effects of chlorpropamide and tolbutamide. Diabetes 14, 650–657 (1965).

    PubMed  CAS  Google Scholar 

  • Keen, H., Jarrett, R.J., Fuller, J.H.: Tolbutamide and arterial disease in borderline diabetics. In: Proceedings of the Eighth Congress of the Int. Diabetic Fed. Eds. W.J. Kalaisse and J. Pirart, p. 588–602. Amsterdam: Excerpta Med., 1974.

    Google Scholar 

  • Keen, H., Jarrett, R.J., Ward, J.D., Fuller, J.H.: Borderline diabetics and their response to tolbutamide. In: Vascular and Neurological Changes in Early Diabetes. Eds. R.A. Camerini-Davalos and H.S. Colo, p. 521–531, New York: Academic Press 1973.

    Google Scholar 

  • Keen, H.: Minimal diabetes and arterial disease. Prevalence and the effect of treatment. In: Early Diabetes (Camerini-Davalos, Cole, eds.), pp. 437–442. New York: Academic Press 1970.

    Google Scholar 

  • Kemball, M.L., McIver, C., Milner, R.D.G., Nourse, C.H., Schiff, D., Tiernan, J.R.: Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch. Dis. Childh. 45, 696–701 (1970).

    PubMed  CAS  Google Scholar 

  • Kirtley, W.R.: Occurence of sensitivity and side reaction following carbutamide. Diabetes 6, 72–73 (1957).

    PubMed  CAS  Google Scholar 

  • Krause, U.: Tolbutamid und Myocardinfarkt. Pharm. Ztg. (Frankfurt) 15, 523 (1971).

    Google Scholar 

  • Lahon, H.J.F., Mann, R.D.: Glipizide — results of a multicentre clinical trial. J. int. med. Res. 1, 608–615 (1973).

    Google Scholar 

  • Lasseter, K.C., Levey, G.S., Palmer, R.F., McCarthy, J.S.: The effect of sulfonylurea drugs on rabbit myocardial contractility, canine Purkinje fiber automaticity and adenyl cyclase activity from rabbit and human hearts. J. clin. Invest. 51, 2429–2434 (1972).

    PubMed  CAS  Google Scholar 

  • Lawter, D.E. de, Moss, J.M., Tyroler, S.A., Canary, J.J.: Secondary failure of response to tolbutamide treatment. J. Amer. med. Ass. 171, 1786–1792 (1959).

    Google Scholar 

  • Lazarus, S.S., Volk, B.W.: Absence of teratogenic effects of tolbutamide in rabbits. J. clin. Endocr. 23, 597–599 (1963).

    CAS  Google Scholar 

  • Levey, G.S., Palmer, R.F., Lasseter, K.C., McCarthy, J.S.: Effects of tombutamide on adenyl cyclase in rabbit and human heart and contractility of isolated rabbit atria. J. clin. Endocrinol. Metab. 33, 371–374 (1971).

    PubMed  CAS  Google Scholar 

  • Liebel, B.: An analysis of the University Group Diabetes Study Program: data, results and conclusions. Canad. med. Ass. J. 105, 292–294 (1971).

    Google Scholar 

  • Loubatieres, A.: Étude physiologique et pharmacodynamique de certain dérivés sulfamidés hypoglycaemiants. Arch. int. Physiol. 54, 174–177 (1946 a).

    CAS  Google Scholar 

  • Loubatieres, A.: Physiologie et pharmacodynamic de certains dérivés sulfamidés hypoglycémients. Contribution à l’étude des substances synthétiques à tropism endocrinien. Thèses. Montpellier: Causse, Graille et Castelnau 1946 b.

    Google Scholar 

  • Loubatieres, A.: Action curative du p-amino-benzène-sulfamido-isopropylthiodiazol dens le diabète sucré humain. C.R. Acad. Sei. (Paris) 241, 1422–1423 (1955).

    CAS  Google Scholar 

  • Loubatieres, A., Mariani, M.M.: Etude pharmacolique et pharmacodynamique d’un sulfonyluree hypoglycemiante particulièrement actil, le glybenzeyelamide. C. R. Acad. Sei. (Paris) 265, 643–645 (1967).

    Google Scholar 

  • Loubatieres, A., Mariani, M.M., Ribes, G., Alric, R.: Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glizoxepide). Acta Diabetolog. Lat. 10, 261–282 (1973).

    Google Scholar 

  • Malins, J.M., Cooke, A.M., Pyke, D.A., Fitzgerald, M.G.: Sulphonylurea drugs during pregnancy. Brit. med. J. 1964 II, 187.

    Google Scholar 

  • Mehnert, H.: Clinical results after 10 years treatment with tolbutamide. In: Tolbutamide — after 10 years (Butterfield, Westering, eds.), pp. 281–285. New York: Excerpta Medica 1967.

    Google Scholar 

  • Mehnert, H., Seitz, W.: Weitere Ergebnisse der Diabetesbehandlung mit blutzuckersenkenden Biguaniden. Münch, med. Wschr. 100, 1849–1851 (1958).

    CAS  Google Scholar 

  • Meinders, A.E., Touber, J.L., De Vries, L.A.: Chlorpropamide treatment in diabetes insipidus. Lancet 1967 II, 544–546.

    Google Scholar 

  • Meyer, R. de: 4e Congrès de la Fédération Internationnale du Diabète, Geneva 1961, pp. 401–403.

    Google Scholar 

  • Meyer, R. de, Isaac-Mathy, M.: A propos de l’action tératogène d’un sulfamide hypoglycémiant (N-sulfanilyl-N’-butylurée BZ55). Ann. Endoer. (Paris) 19, 167–172 (1958).

    Google Scholar 

  • Miller, D.I., Wishinsky, H., Thompson, G.: Transfer of tolbutamide across the human placenta. Diabetes 11, Suppl. 93–97 (1962).

    Google Scholar 

  • Miller, M., Moses, A.M.: Mechanism of chlorpropamide action in diabetes insipidus. J. clin. Endocrinol. 30, 488–496 (1970).

    CAS  Google Scholar 

  • Mohnike, G., Stötter, G.: Klinische Ergebnisse mit D 860. Dtsch. med. Wschr. 81, 826–835 (1956).

    CAS  Google Scholar 

  • Moiel, R.H., Ryan, J.R.: Tolbutamide Orinase in human breast milk. Clin. Pediat. 6, 480 (1967).

    PubMed  CAS  Google Scholar 

  • Moses, A.M., Howanitz, J., Miller, M.: Diuretic action of three sulfonylurea drugs. Ann. intern. Med. 78, 541–544 (1973 a).

    PubMed  CAS  Google Scholar 

  • Moses, A.M.L., Numann, P., Miller, M.: Mechanism of chlorpropamide-induced diuresis in man. Evidence for release of ADH and enhancement of peripheral action. Metabolism 22, 59–66 (1973b).

    PubMed  CAS  Google Scholar 

  • Müller, R., Bauer, C., Schröder, R., Saito, S.: Summary report of clinical investigation of the oral antidiabetic drug HB 419 (Glibenclamide). Horm. Metab. Res. 1, Suppl., 88–92 (1969).

    Google Scholar 

  • O’Donovan, C.J.: Analysis of long-term experience with tolbutamide (orinase) in the management of diabetes. Curr. ther. Res. 1, 69–87 (1959).

    PubMed  Google Scholar 

  • Otto, H., Mikosch, M., Otto-Bendfeldt, E.: Indikationen für die kombinierte Anwendung von Insulin und Sulfonylharnstoffen in der Diabetesbehandlung. Med. Welt (Stuttg.) 17, 1864 (1966).

    Google Scholar 

  • Paasikivi, J.: Long-term tolbutamide treatment after myocardial infarction. A clinical and biochemical study of 178 patients without overt diabetes. Acta med. scand. 187 (Suppl. 507), 1–82 (1970).

    Google Scholar 

  • Pell, S., D’Alonzo, C.A.: Factors associated with long term survival of diabetes. J. Amer. med. Ass. 214, 1833–1840 (1970).

    CAS  Google Scholar 

  • Petzold, C., Riedesel, H., Ramrath, M., Grabs, V., Haupt, E., Schwedes, W., Ekald, W., Beyer, J., Schöffling, K.: Klinische Erfahrungen mit dem blutzuckersenkenden Sulfonamidderivat Glisoxepid. Arzneimittel-Forsch. 24, 429–432 (1974).

    Google Scholar 

  • Podgainy, H., Bressler, R.: Biochemical basis of the sulphonylurea-induced antabuse syndrome. Diabetes 17, 679–682 (1968).

    PubMed  CAS  Google Scholar 

  • Prout, T.E., Knatterud, G.L., Meinert, C.L., Klimt, C.R.: The UGDP Controversy: Clinical trials versus clinical impressions. Diabetes 21, 1035–1040 (1972).

    PubMed  CAS  Google Scholar 

  • Rädo, J.P., Borbely, L., Szende, L., Tako, J.: Decrased antidiuretic response to lysine-vasopressin 1971 II, 216.

    Google Scholar 

  • Rado, J.P., Borbely, L., Szende, L., Tako, J.: Decreased antidiuretic response to lysine-vasopressin after acute administration of glibenclamide in healthy subjects. Acta Diabetolog. Lat. II, 18–25 (1974).

    Google Scholar 

  • Raptis, S., Rau, R.M., Schröder, K.E., Faulhaber, J.D., Pfeiffer, E.F.: Comparative study of insulin secretion following repeated administration of glucose, tolbutamide and glibenclamide (HB 419) in diabetic and non-diabetic human subjects. J. Horm. Metab. Res. I (Suppl.), 65–72 (1969).

    Google Scholar 

  • Redman, D.R., Prescott, L.F.: Failure of induction of liver microsomal enzymes by tolbutamide in maturity-onset diabetes. Diabetes 22, 210–211 (1973).

    PubMed  CAS  Google Scholar 

  • Retiene, K., Petzoldt, R., Althoff-Zucker, C., Beyer, J., Schöfeling, K.: Clinical studies on glibenclamide (HB 419). Horm. Metab. Res. 1, Suppl., 55–60 (1969).

    Google Scholar 

  • Ricketts, H.T.: The influence of diabetic control on angiopathy. IN: On the nature and treatment of diabetes (Leibel, Wrenshall, eds.), pp. 588–600. Amsterdam-New York: Excerpta Medica 1965.

    Google Scholar 

  • Ruiz, C.L., Silva, L.L., Libenson, L.: Contribucion al estudio solre la composicion quimica de la insulina. Estudio de algunos cuerpos sinteticas sulfurados con accion hypoglucemiante. Rev. Soc. argent. Biol. 6, 134–141 (1930).

    CAS  Google Scholar 

  • Savagnone, L.: Sulfamidi e ricambio idrocarbonato influenze della somministrazione di sulfamidi sul tasso glicemico in condizioni normali e patologiche. Settim. med. 29, 1005 (1941).

    Google Scholar 

  • Schmidt, H.A.E., Schoog, M., Schweer, K.H., Winkler, E.: Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic. Diabetologia, Suppl. 9, 320–330 (1973).

    CAS  Google Scholar 

  • Schöfeling, K., Mehnert, H., Ewald, W., et al.: Behandlung der Erwachsenendiabetes mit Glibernurid Ergebnisse einer klinischen Studie. Dtsch. med. Wschr. 98, 915–919 (1973).

    Google Scholar 

  • Schor, S.S.: The University Group Diabetes Program: A statistician looks at the mortality results. J. Amer. med. Ass. 217, 1671–1675 (1971).

    CAS  Google Scholar 

  • Schor, S.S.: Statistical problems in clinical trials: the UGDP Study revisited. Amer. J. Med. 55, 727–732 (1973).

    PubMed  CAS  Google Scholar 

  • Seltzer, H.S.: A summary of criticism of the findings and conclusions of the University Group Diabetes Program (UGDP). Diabetes 21, 976–979 (1972).

    PubMed  CAS  Google Scholar 

  • Sheldon, J., Anderson, J., Stoner, L.: Serum concentrations and urinary excretion of oral sulfonylurea compounds. Relation to diabetic control. Diabetes 14, 362–367 (1965).

    PubMed  CAS  Google Scholar 

  • Sterne, J.: Du nouveau dans les antidiabetiques, la N-N-dimethylaminoguanylguanidine. Maroc med. 106, 1295–1307 (1957).

    Google Scholar 

  • Stowers, J.M., Mahler, R.F., Hunter, R.B.: Pharmacology and mode of action of the sulphonylureas in man. Lancet 19581, 278–283.

    Google Scholar 

  • Stowers, J.M.: Prevention of diabetes. Clinical results. In: Diabetes (Östman, ed.), pp. 743–746. Amsterdam: Excerpta Medica 1969.

    Google Scholar 

  • Stowers, J.M.: Glibenclamide for secondary failures of other sulphonylureas. Postgrad, med. J. 46, Suppl. 63–65 (1970a).

    Google Scholar 

  • Stowers, J.M.: Treatment of subclinical diabetes. In: Early Diabetes (Camcrini-Dávalos, Cole, eds.), pp. 449–454. New York: Academic Press 1970b.

    Google Scholar 

  • Teuscher, A.: Sind orale Antidiabetika unwirksam — oder gar gefährlich? Das „University Group Diabetes Program“ (UGDP) als Ausgangspunkt einer Kontroverse über die Therapie des Altersdiabetes. Schweiz, med. Wschr. 102, 848–855 (1972).

    CAS  Google Scholar 

  • Tuchmann-Duplessis, H., Mercier-Parot, L.: Sur Taction teratogene de l’amino-phenurobutane (BZ 55) chez la ratte. C.R. Soc. Biol. (Paris) 152, 460–463 (1958).

    CAS  Google Scholar 

  • Tuchmann-Duplessis, H., Mercier-Parot, L.: J. Ann. Diabet. de l’Hotel Dieu (Paris) 3, 141–149 (1962).

    CAS  Google Scholar 

  • Ueda, H., Sakurai, T., Ota, M., Nakajima, A., Kamii, K., Maezawa, H.: Disappearance rate of tolbutamide in normal subjects and in diabetes mellitus, liver cirrhosis and renal disease. Diabetes 12, 414–419 (1963).

    PubMed  CAS  Google Scholar 

  • Ungar, G., Freedman, L., Shapiro, S.L.: Pharmacological studies of a new hypoglycaemic drug. Proc. Soc. exp. Biol. (N.Y.) 95, 190–192 (1957).

    CAS  Google Scholar 

  • Unger, R.H., Madison, L.L., Carter, N.W.: Tolbutamide-phenformin in ketoacidosis-resistant patients. J. Amer. med. Ass. 174, 2132–2136 (1960).

    CAS  Google Scholar 

  • University Group Diabetes Program: A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19, Suppl. 2, 747–830 (1970 a).

    Google Scholar 

  • University Group Diabetes Program: A study of the effect of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. Report of the Food and Drug Administration. Diabetes 19, (Suppl. 2), viii–ix (1970b).

    Google Scholar 

  • Weber, H., Aumüller, W., Fauland, E., Heerdt, R., Hubner, M., Muth, K., Weyer, R.: Development and chemistry of HB 419 and related compounds. Horm. Metab. Res. 1 (Suppl.), 1–3 (1969).

    Google Scholar 

  • Weissman, P.N., Shenkman, L., Gregerman, R.I.: Chlorpropamide hyponatraemia. New Engl. J. Med. 284, 65–71 (1971).

    PubMed  CAS  Google Scholar 

  • White, P.: Pregnancy and diabetes: medical aspects. Med. Clin. N. Amer 49, 1015–1024 (1965).

    PubMed  CAS  Google Scholar 

  • Willes, B., Deudicke, U.: Alkoholunverträglichkeit durch Pro-Diaban und andere Sulfonylharnstoffe. In: Pro-Diaban (Glisoxepid) Symposium. Eds. K. Schöffling etal., p. 165–169, Stuttgart: F.K. Schattauer 1974.

    Google Scholar 

  • Wolff, F.W., Stewart, G.A., Crowley, M.F., Bloom, A.: Trial of an oral hypoglycaemic agent in diabetes. Brit. med. J. 1956 II, 440–445.

    Google Scholar 

  • Young, J.L., Burr, I.M., Perry, J.M., Nelson, J.H., Nies, A.S.: Inotropic effect of tolbutamide in man. Amer. Heart J. 89, 189–194 (1975).

    PubMed  CAS  Google Scholar 

  • Zöllner, N., Dorfler, H., Wolfram, G.: Klinische Prüfung des Sulfonylharnstoffderivats Glibornurid. Dtsch. med. Wschr. 97, 1083–1088 (1972).

    PubMed  Google Scholar 

Download references

Authors
  1. B. F. Clarke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. J. P. Duncan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chemie Grünenthal GmbH, Zweifallstraße, D-5190, Stolberg, Germany

    R. Beckmann

  2. II. Medizinische Universitätsklinik und Poliklinik, Moorenstraße 5, D-4000, Düsseldorf, Germany

    M. Berger

  3. Am Hof 11, A-1010, Wien, Austria

    A. Beringer

  4. II. Medizinische Universitätsklinik und Poliklinik, Moorenstr. 5, D-4000, Düsseldorf, Germany

    P. Berchtold

  5. D-6500, Mainz, Germany

    J. Beyer (Leiter der Abteilung für klinische Endokrinologie an der II. Medizinischen Klinik und Poliklinik des Klinikums der Johannes Gutenbergschen Universität) (Leiter der Abteilung für klinische Endokrinologie an der II. Medizinischen Klinik und Poliklinik des Klinikums der Johannes Gutenbergschen Universität)

  6. Inselspital, CH-3010, Bern, Switzerland

    A. Bischoff (Chefarzt der Neurologischen Universitätsklinik) (Chefarzt der Neurologischen Universitätsklinik)

  7. Hautklinik, Städtische Krankenanstalten, Bremserstraße 79, D-6700, Ludwigshafen, Germany

    G. Brehm (Direktor der Hautklinik) (Direktor der Hautklinik)

  8. Diabetic and Dietetic Department, The Royal Infirmary, EH3 9YW, GB-Edinburgh, UK

    B. F. Clarke

  9. Tödisstraße 36, CH-8002, Zürich, Switzerland

    G. R. Constam

  10. Diabetic and Dietetic Department, The Royal Infirmary, EH3 9YW, GB-Edinburgh, UK

    L. J. P. Duncan

  11. Diabetes-Forschungsinstitut an der Universität, Auf’m Hennekamp 65, D-4000, Düsseldorf, Germany

    F. A. Gries (Direktor der Klinischen) (Direktor der Klinischen)

  12. Institut für Pharmakologie und Toxikologie der Universität, Geiststraße 9, D-3400, Göttingen, Germany

    A. Hasselblatt

  13. Medizinische Klinik, St. Josefskrankenhaus, Landhausstraße 25, D-6900, Heidelberg, Germany

    R. Hild

  14. 2. Medizinische Klinik und Poliklinik, Klinishe Anstalten der Universität, Moonrenstraße 5, D-4000, Düsseldorf 1, Germany

    K. Irmscher

  15. Medizinische Klinik, Städtisches Ferdinand-Sauerbruch-Klinikum, Arrenberger Straße, D-5600, Wuppertal 1, Germany

    K. Jahnke

  16. I. Medizinische Universitätsklinik, Martinistraße 52, D-2000, Hamburg 20, Germany

    J. Kühnau

  17. Evangelisches Fliedner-Krankenhaus, D-6680, Neunkirchen, Germany

    H. Liebermeister

  18. Kommunenhospitalet, 2. Medizinische Universitätsklinik, DK-Aarhus, Denmark

    K. Lundbaek

  19. Klinikum Essen, Hufelandstraße 55, D-4300, Essen 1, Germany

    G. Meyer-Schwickerath (Direktor der Universitäts-Augenklinik) (Direktor der Universitäts-Augenklinik)

  20. Wittenberger Straße 81, D-4230, Wesel 13, Germany

    Sigrid Napp-Mellinghoff

  21. Abteilung für Endokrinologie, Zentrum der Inneren Medizin, Theodor-Stern-Kai 7, D-6000, Frankfurt/Main 70, Germany

    M. Neubauer

  22. Department für innere Medizin der Universität, Steinhövelstraße 9, D-7900, Ulm, Germany

    F. Nobbe

  23. BW-Krankenhaus, Mähringer Weg 105, D-7900, Ulm, Germany

    F. Nobbe

  24. Schloßmannstraße 32, D-4000, Düsseldorf 1, Germany

    Karl Oberdisse

  25. Heerstraße 219, D-4100, Duisburg, Germany

    P. Petrides (Chefarzt der inneren Abteilung des Bethesda-Krankenhauses) (Chefarzt der inneren Abteilung des Bethesda-Krankenhauses)

  26. Abteilung für Endokrinologie, Zentrum der Inneren Medizin der Universität, Theodor-Stern-Kai 7, D-6000, Frankfurt/Main 70, Germany

    R. Petzoldt  & K. Schöffling  & 

  27. Diabetesklinik, Wielandstraße 23, D-4970, Bad Oeynhausen, Germany

    H. Sauer

  28. Universitäts-Augenklinik, Hufelandstraße 55, D-4300, Essen 41, Germany

    M. Spitznas

  29. Augenklinik, Städtische Krankenanstalten, Hufelandstraße 55, D-4300, Essen 1, Germany

    M. Vogel

  30. Klinische Abteilung, Diabetes-Forschungsinstitut an der Universität, auf’m Hennekamp 65, D-4000, Düsseldorf 1, Germany

    K. H. Vogelberg

  31. Abteilung und Lehrstuhl IV, Retinologie, Universitäts-Augenklinik, Schleichstraße 12, D-7400, Tübungen, Germany

    A. Wessing

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Springer-Verlag Berlin· Heidelberg

About this chapter

Cite this chapter

Clarke, B.F., Duncan, L.J.P. (1977). Sulfonylharnstoff-Therapie. In: Beckmann, R., et al. Diabetes mellitus • B. Handbuch der inneren Medizin, vol 7 / 2 / B. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66379-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66379-6_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-66380-2

  • Online ISBN: 978-3-642-66379-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation